289 related articles for article (PubMed ID: 23878237)
1. Capturing the mutational landscape of the beta-lactamase TEM-1.
Jacquier H; Birgy A; Le Nagard H; Mechulam Y; Schmitt E; Glodt J; Bercot B; Petit E; Poulain J; Barnaud G; Gros PA; Tenaillon O
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13067-72. PubMed ID: 23878237
[TBL] [Abstract][Full Text] [Related]
2. A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.
Sideraki V; Huang W; Palzkill T; Gilbert HF
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):283-8. PubMed ID: 11114163
[TBL] [Abstract][Full Text] [Related]
3. Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories.
Guthrie VB; Allen J; Camps M; Karchin R
PLoS Comput Biol; 2011 Sep; 7(9):e1002184. PubMed ID: 21966264
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Description of a Protein Fitness Landscape Based on Molecular Features.
Meini MR; Tomatis PE; Weinreich DM; Vila AJ
Mol Biol Evol; 2015 Jul; 32(7):1774-87. PubMed ID: 25767204
[TBL] [Abstract][Full Text] [Related]
5. Enzyme Efficiency but Not Thermostability Drives Cefotaxime Resistance Evolution in TEM-1 β-Lactamase.
Knies JL; Cai F; Weinreich DM
Mol Biol Evol; 2017 May; 34(5):1040-1054. PubMed ID: 28087769
[TBL] [Abstract][Full Text] [Related]
6. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
Orencia MC; Yoon JS; Ness JE; Stemmer WP; Stevens RC
Nat Struct Biol; 2001 Mar; 8(3):238-42. PubMed ID: 11224569
[TBL] [Abstract][Full Text] [Related]
7. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
Thomson CJ; Amyes SG
J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
[TBL] [Abstract][Full Text] [Related]
8. The Fitness of Beta-Lactamase Mutants Depends Nonlinearly on Resistance Level at Sublethal Antibiotic Concentrations.
Farr AD; Pesce D; Das SG; Zwart MP; de Visser JAGM
mBio; 2023 Jun; 14(3):e0009823. PubMed ID: 37129484
[TBL] [Abstract][Full Text] [Related]
9. Initial mutations direct alternative pathways of protein evolution.
Salverda ML; Dellus E; Gorter FA; Debets AJ; van der Oost J; Hoekstra RF; Tawfik DS; de Visser JA
PLoS Genet; 2011 Mar; 7(3):e1001321. PubMed ID: 21408208
[TBL] [Abstract][Full Text] [Related]
10. Mutation supply and the repeatability of selection for antibiotic resistance.
van Dijk T; Hwang S; Krug J; de Visser JAGM; Zwart MP
Phys Biol; 2017 Aug; 14(5):055005. PubMed ID: 28699625
[TBL] [Abstract][Full Text] [Related]
11. Shifting Fitness and Epistatic Landscapes Reflect Trade-offs along an Evolutionary Pathway.
Steinberg B; Ostermeier M
J Mol Biol; 2016 Jul; 428(13):2730-43. PubMed ID: 27173379
[TBL] [Abstract][Full Text] [Related]
12. Darwinian evolution can follow only very few mutational paths to fitter proteins.
Weinreich DM; Delaney NF; Depristo MA; Hartl DL
Science; 2006 Apr; 312(5770):111-4. PubMed ID: 16601193
[TBL] [Abstract][Full Text] [Related]
13. SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
Winkler ML; Bonomo RA
Mol Biol Evol; 2016 Feb; 33(2):429-41. PubMed ID: 26531195
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive, high-resolution map of a gene's fitness landscape.
Firnberg E; Labonte JW; Gray JJ; Ostermeier M
Mol Biol Evol; 2014 Jun; 31(6):1581-92. PubMed ID: 24567513
[TBL] [Abstract][Full Text] [Related]
15. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
[TBL] [Abstract][Full Text] [Related]
16. A natural polymorphism in beta-lactamase is a global suppressor.
Huang W; Palzkill T
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8801-6. PubMed ID: 9238058
[TBL] [Abstract][Full Text] [Related]
17. Environmental changes bridge evolutionary valleys.
Steinberg B; Ostermeier M
Sci Adv; 2016 Jan; 2(1):e1500921. PubMed ID: 26844293
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the causes of adaptive benefits of synonymous mutations in TEM-1 β-lactamase.
Zwart MP; Schenk MF; Hwang S; Koopmanschap B; de Lange N; van de Pol L; Nga TTT; Szendro IG; Krug J; de Visser JAGM
Heredity (Edinb); 2018 Nov; 121(5):406-421. PubMed ID: 29967397
[TBL] [Abstract][Full Text] [Related]
19. Adaptive benefits from small mutation supplies in an antibiotic resistance enzyme.
Salverda MLM; Koomen J; Koopmanschap B; Zwart MP; de Visser JAGM
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12773-12778. PubMed ID: 29133391
[TBL] [Abstract][Full Text] [Related]
20. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
Thomson CJ; Amyes SG
J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
